December 2017 Initial Public Offerings

Notable initial public offerings (IPOs) during the month of December 2017 included:

• Odonate Therapeutics listed on the NASDAQ under the ticker symbol ODT. The company raised $150 million from the issuance of 6.3 million shares at $24.00 per share. The company is currently developing an oral chemotherapy drug for breast cancer.
• San Francisco-based Denali Therapeutics (NASDAQ: DNLI) raised $250 million on 13.9 million shares at $18.00 per share. The company, which was founded in 2015, manufactures drugs that combat Alzheimer’s, Parkinson’s, and ALS.
• Newmark Group (NASDAQ: NMRK), a commercial real estate brokerage and advisory group, raised $280 million by offering 20 million shares at $14.00 per share. The offering was revised from an initial planned IPO of 30 million shares at a range of $19.00 to $22.00 per share just days before its debut.